Sensory Profile and Early Clinical Signs of Calm Room Users (EVAL-APAISE)

Centre Hospitalier Esquirol

Status: Enrolling

Conditions: Psychotic Disorders; Mood Disorders; Personality Disorders

Treatments: Other: Calm room

Study type: Observational

Funder types: Other

Identifiers

NCT06839950

EVAL-APAISE

2023-A00580-45 (Registry Identifier)

Details and patient eligibility

About

This descriptive study aims primarily to characterize the sensory profile of patients in a closed psychiatric hospital unit who use a calming room.

The main questions it aims to answer are :

• Could sensory information processing disorders be the cause of distress and tension in these patients?
• Could users of the calming room present extreme sensory processing profiles, characterized by either hypersensitivity or hyposensitivity ?

Participants will answer a survey to determine their the sensory profile. Participants can already use the calming room as part of their regular medical care and they will answer surveys before and after each use.

Enrollment: 80 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Gender and Age: Male or female, aged 18 to 65
• Hospitalization: Admitted to the closed hospitalization unit for less than 10 days
• Social security: Affiliated or beneficiary of a social security system
• Consent: Free, informed, and written consent, signed by the participant and/or their legal representative (for participants under protection measures) and the investigator (at the latest on the day of inclusion and before any research-related examination).

Exclusion criteria

• Inability to understand information related to the study
• Proven sensory disability
• Dementia
• Pregnancy
• Lack of social protection
• Previous Participation in this research protocol (in the case of a new hospitalization)
• Expression abilities incompatible with completing the AASP Scale (e.g., french language comprehension issues, mute individuals, patients in restraint and/or therapeutic isolation)